ライフサイエンスコーパス: survival advantage

1 r reptiles, anaphylaxis might even provide a survival advantage.

2 liferator-activated receptor-alpha confers a survival advantage.

3 on and/or ablation was not associated with a survival advantage.

4 use the adaptive ER stress response to gain survival advantage.

5 sociated with PB transplantation may offer a survival advantage.

6 flammatory gut diseases and gains a distinct survival advantage.

7 ough 1,200-1,400 ft conferred an incremental survival advantage.

8 subvert host innate immune responses for its survival advantage.

9 come in malignant transformation to confer a survival advantage.

10 rant lipid signaling and metabolism as their survival advantage.

11 and let-7 suppressed tumor growth leading to survival advantage.

12 th such changes, in addition to conferring a survival advantage.

13 -/-) mice, unlike F12(-/-) mice, do not have survival advantage.

14 display diminished mitotic errors and have a survival advantage.

15 that increased genetic diversity provides a survival advantage.

16 ic for diseases in which donor cells have no survival advantage.

17 Conversely, mutation of phtD conferred a survival advantage.

18 n within the glioma as well as a substantial survival advantage.

19 importantly, LGP2 TG mice had a significant survival advantage.

20 mma receptors, providing the bacteria with a survival advantage.

21 r of patients with severe sepsis may offer a survival advantage.

22 e cancer (PCa) cells and that this confers a survival advantage.

23 Neighborhood factors slightly moderate this survival advantage.

24 plified, and DeltaNp63alpha confers a potent survival advantage.

25 ute respiratory distress syndrome, regarding survival advantage.

26 th IL-5 family cytokines no longer confers a survival advantage.

27 hat provide a tumor a significant growth and survival advantage.

28 peration is safe and confers a risk-adjusted survival advantage.

29 ly to external stimuli may gain a growth and survival advantage.

30 roversy surrounding the significance of this survival advantage.

31 ain fatty acid receptor GPR43 abolished this survival advantage.

32 LL cells with a microenvironment-independent survival advantage.

33 , this did not appear to convey a comparable survival advantage.

34 and cells that have engulfed others obtain a survival advantage.

35 crophages, thereby exacerbating its relative survival advantage.

36 taxel, which was associated with a long-term survival advantage.

37 e systems may, in part, explain the Canadian survival advantage.

38 iven lung cancer, resulting in a significant survival advantage.

39 Surgery conferred no long-term survival advantage.

40 pporting the concept that ST6Gal-I confers a survival advantage.

41 ovel cotreatment strategies to override this survival advantage.

42 als in the first-line setting have not shown survival advantages.

43 ifferences in signal strength translate into survival advantages.

44 n of the Akt pathway is responsible for cell survival advantages.

45 ansformed phenotype by conferring growth and survival advantages.

46 ter treatment compliance, and may even offer survival advantages.

47 ectin-like domain of thrombomodulin showed a survival advantage, accompanied by decreased bacterial l

48 graft dysfunction does not appear to confer survival advantage after intestinal transplantation.

49 o damaged chromatin completely abolished the survival advantage after multifractionated irradiation a

50 prostate stem cells would provide ERG-driven survival advantages, allowing maintenance of this mutate

51 hat warm-adapted species carry a significant survival advantage amidst the synergistic impacts of lan

52 It is associated with a significant survival advantage among high-risk infants, and this adv

53 e Recently, a large randomized trial found a survival advantage among patients who received elective

54 e emergency treatment, there was a long-term survival advantage among patients who underwent CABG as

55 ention ICD was associated with a significant survival advantage among women and among men.

56 than single agents but do not demonstrate a survival advantage and are associated with increased tox

57 cellular carcinoma, but the relation between survival advantage and disease etiology remains unclear.

58 nter more and miss less reward, resulting in survival advantage and enhanced evolutionary fitness.

59 isseminated to murine lungs demonstrated the survival advantage and increased colonization ability of

60 not negatively impact the living-donor graft survival advantage and provides similar cumulative graft

61 The survival advantage and relapse protection in C1/x recipi

62 ndings show that education-dependent NK cell survival advantages and killing of uneducated NK cells r

63 among thousands acquiring proliferation and survival advantages and ultimately becoming pathogenic.

64 ecruit metastatic cancer cells and provide a survival advantage, and their use as a diagnostic platfo

65 on with self-pMHC ligands imparts growth and survival advantages as revealed in thymic stromal cultur

66 genes by KSHV could also provide a potential survival advantage, as the expression of proteins at imm

67 However, we did not observe a survival advantage associated with total thyroidectomy c

68 ent's perspective, which integrates not only survival advantage but also disease-associated and adver

69 ds to more compact patches that enhance this survival advantage but also reduce the overall growth.

70 treatment was not associated with an overall survival advantage but was significantly associated with

71 ls to sites of infection but also provides a survival advantage by dampening excessive inflammation t

72 iscrimination according to colour can confer survival advantages by guiding animals towards food and

73 CXCR4 (X4)-, and dual-tropic HIV-1 and had a survival advantage compared to control cells ex vivo In

74 nsplantation was associated with a long-term survival advantage compared to dialysis, but there were

75 ated that PSC patients have a positive graft survival advantage compared to non-PSC patients (hazard

76 iving donor (LD) recipients had an immediate survival advantage compared to similar risk wait-listed

77 at, in aggregate, has resulted in an overall survival advantage compared with breast-conserving surge

78 mbination therapy might be associated with a survival advantage compared with initial monotherapy in

79 were associated with a small but significant survival advantage compared with moderate-intensity stat

80 OCS3) were associated with a 10- and 6-month survival advantage compared with noncarriers in patients

81 Successful PAK offers a survival advantage compared with receiving neither a kid

82 ponses to topotecan, producing a significant survival advantage compared with subjects treated with t

83 No larynx-preservation approach offered a survival advantage compared with total laryngectomy and

84 nt recipients who receive both organs have a survival advantage compared with uremic candidates who r

85 Surgical interventions confer survival advantages compared with palliative therapies f

86 y alone or combined with cisplatin showed no survival advantage, compared with control groups (all, P

87 onal wild-type allele; or as a result of the survival advantage conferred by mutant p53 to which canc

88 nts abrogate this cytotoxicity, indicating a survival advantage conferred by the FAM46C mutant phenot

89 Clinical studies reported a potent survival advantage conferred by the oxazolidinone and ca

90 node primary tumor did not have disease-free survival advantage despite surgical margin clearance (9

91 dent up-regulation gave Tsc1(null) neurons a survival advantage, despite their misplacement in a nove

92 tial mortality rates than whites, this early survival advantage did not persist during long-term foll

93 6/STAT3 pathway in tumor cells may provide a survival advantage during anti-VEGF treatment, suggestin

94 as well as glucose, for energy, conferring a survival advantage during feast and famine.

95 anipulates several cellular pathways for its survival advantage during its latency in the infected hu

96 that the expression of Shh by MCs confers a survival advantage during the response to excitotoxic in

97 odel includes known spatial variation in the survival advantage enjoyed by the yellow morph and assum

98 ls in some regions were not experiencing the survival advantage expected at given levels of mortality

99 As mitochondrial transfer provides a clear survival advantage following chemotherapy and a higher l

100 We then explored the antitumor efficacy with survival advantage following foretinib and lapatinib mon

101 gher social integration is associated with a survival advantage for Blacks and Whites.

102 ndomized phase III data to date supporting a survival advantage for combining molecularly targeted ag

103 The survival advantage for EVAR repair in a statewide popula

104 atabase studies have demonstrated a powerful survival advantage for ICD patients undergoing RM compar

105 There was an early (to discharge) survival advantage for infants before next-stage surgery

106 A survival advantage for overweight and obese patients was

107 nstrumental variables analysis, there was no survival advantage for patients treated in centers where

108 rall, allograft survival analysis revealed a survival advantage for patients who normalize PTH within

109 However, previous studies could not show a survival advantage for patients with AL amyloidosis resp

110 Centralised multidisciplinary care confers a survival advantage for patients with ALS and is superior

111 ey transplantation confers a well-documented survival advantage for patients with end-stage renal dis

112 d might have a small but clinically relevant survival advantage for patients with spontaneous superfi

113 some older patients with MDS, there may be a survival advantage for RIC HSCT compared with nontranspl

114 Previous studies have not shown a survival advantage for smoking reduction.

115 on is superior to remaining on dialysis, the survival advantage for SPK recipients compared to kidney

116 osis, and experience with CML, a significant survival advantage for TH patients (hazard ratio: 0.632

117 oposed transesterification indeed provides a survival advantage for the producing microorganism.

118 rk has evaluated functional improvements and survival advantage for these techniques, although their

119 based on older data demonstrating an overall survival advantage for total thyroidectomy over lobectom

120 by the EGFR/GSTP1 cross-talk and provides a survival advantage for tumors with activated EGFR and hi

121 The average 10% survival advantage for women persisted throughout this p

122 n elevated frequencies of alleles conferring survival advantages for infectious diseases, but that ar

123 bit true division of labor, providing growth/survival advantages for the whole community.

124 transcription factor T-bet did not gain any survival advantage from RABV infection, exhibiting only

125 te hemoconcentration conferred a significant survival advantage (hazard ratio: 0.74 [95% confidence i

126 surgery compared with surgery alone showed a survival advantage (HR = 0.83, 95% CI 0.76-0.90), wherea

127 ith adjuvant therapies showed no significant survival advantage (HR = 0.87, 95% CI 0.67-1.14).

128 ore-forming sulfate-reducing bacteria have a survival advantage if they are introduced to, or are res

129 Treatment with EP was not associated with a survival advantage in a Cox proportional hazards model (

130 TTM also provided a survival advantage in a genetically engineered mouse mod

131 n, attenuation of multiple organ damage, and survival advantage in a mouse model of sickle cell disea

132 or effector cell population, Bcl-2 confers a survival advantage in a subset of effector CD8(+) T cell

133 its myeloma cell proliferation, resulting in survival advantage in a systemic myeloma xenograft model

134 t time a controlled study has demonstrated a survival advantage in AL amyloidosis.

135 There was no survival advantage in association with higher total or p

136 -dysfunctional bacteria having a significant survival advantage in biofilm infection because they for

137 This significant survival advantage in both p53WT and p53null leukemic mi

138 our study demonstrate a significant overall survival advantage in both patients who are clinically n

139 ukemia or lymphoma in xenograft models and a survival advantage in comparison to control mice.

140 Phase III clinical trials showing a survival advantage in CRPC for treatment with abirateron

141 f cytopenias) were not uniformly improved, a survival advantage in favor of ruxolitinib therapy was d

142 Genetic diversity is known to confer survival advantage in many species across the tree of li

143 gy, given that a MEK1/2 inhibitor provides a survival advantage in metastatic melanoma, an effect tha

144 ion with cellulose offers a microbe-mediated survival advantage in murine models of sepsis.

145 l infiltration of tumour islets represents a survival advantage in non-small cell lung cancer (NSCLC)

146 ssue, which might contribute to the apparent survival advantage in obese patients with clear cell RCC

147 lly resisting bleaching, these corals had no survival advantage in one species and 3.3 times lower su

148 e is a small, yet statistically significant, survival advantage in patients who have ICP monitors and

149 chemotherapy regimens results in an overall survival advantage in patients with advanced disease who

150 iled to show that beta2AR agonists provide a survival advantage in patients with ALI.

151 eases tumor incidence as well as providing a survival advantage in patients with breast and ovarian c

152 s and infiltrating blast cells, conferring a survival advantage in preclinical xenotransplantation mo

153 an adaptive cellular response that confers a survival advantage in response to sepsis at a cost of de

154 e an ROS-resistant phenotype that provides a survival advantage in the bloodstream and promotes their

155 Although these mutations confer a survival advantage in the presence of rifampin, they may

156 to FFP approaching 1:1 are associated with a survival advantage in traumatic hemorrhage, even in pati

157 ific for melanoma cells displayed a relative survival advantage in tumors.

158 Anti-HER2 treatment has clear survival advantages in HER2-positive breast carcinoma pa

159 ntraperitoneal therapy (IP) has demonstrated survival advantages in patients with peritoneal cancers,

160 ase in copy number of the oncogene, provides survival advantages in solid tumors including malignant

161 This survival advantage is counter-regulated by lipocalin 2,

162 nism by which sleep is proposed to provide a survival advantage is in terms of supporting a neurally

163 ditional open repair, but after 4 years this survival advantage is not seen; in addition, results of

164 This survival advantage is slightly more pronounced in lower

165 ds or natural or synthetic colloids confer a survival advantage is unclear.

166 F2BP3 provided murine BM cells with a strong survival advantage, led to proliferation of hematopoieti

167 The survival advantage may arise for several postulated reas

168 We subsequently show a survival advantage, mounting to 31%, for individuals wit

169 rformed prone positioning offers an absolute survival advantage of 10-17%, making this intervention h

170 e disease-modifying medication and confers a survival advantage of 2-3 months.

171 vivo CXCR3 blockade partially abrogates the survival advantage of an ALK5(DeltaCD8) host.

172 We examined whether the survival advantage of androgen-deprivation therapy with

173 wn bats (Eptesicus fuscus) and demonstrate a survival advantage of approximately 47% for moths with t

174 related pathways in CTC clusters, suggesting survival advantage of clusters in circulation.

175 We show for the first time that there is a survival advantage of DBS surgery in advanced PD.

176 The survival advantage of ET over PV was not affected by JAK

177 Insight into the survival advantage of female patients may advance the mo

178 d to break even is 1:20,000; however, if the survival advantage of HSCT before 3 months is confirmed,

179 The survival advantage of invasive compared with non-invasiv

180 Despite a significant survival advantage of kidney transplantation compared wi

181 Although the long-term survival advantage of multiple arterial grafting (MAG) v

182 ancer, this work demonstrates that gaining a survival advantage of premalignant cells may delay or pr

183 ntermediate-2 or high IPSS risk have shown a survival advantage of ruxolitinib over placebo (COMFORT-

184 A significant survival advantage of sensitizing AML for chemotherapy w

185 A survival advantage of the DAC arm over the DA arm was ob

186 Correlative analyses confirm that the survival advantage of the proneural subtype is conferred

187 d to demonstrate a statistically significant survival advantage of treatment with tremelimumab over s

188 introduction of oncogenic Ras abrogated the survival advantage of TSC2(-/-) MEFs upon ceramide treat

189 m more rapid production and a cell-intrinsic survival advantage of Zbtb32(-/-) secondary plasma cells

190 (Petrochelidon pyrrhonota) to show that the survival advantages of different colony sizes fluctuated

191 ared with PCI, HCR offers the durability and survival advantages of the left internal mammary artery.

192 at the WNT pathway confers proliferative and survival advantages on cap cells via regulation of FOXO1

193 Such a mixotrophic lifestyle would confer survival advantage (or possibly provide a unique narrow

194 t base, termed 'central cells', experience a survival advantage over border stem cells.

195 rapy followed by radiation provides a better survival advantage over chemotherapy alone after upfront

196 but whether systematic screening leads to a survival advantage over clinical diagnosis is uncertain.

197 Anti-PD-1/PD-L1 inhibitors provide a survival advantage over conventional therapies for treat

198 t (TCS) devices afford children a meaningful survival advantage over ECMO.

199 -ventricular assist devices (TCS-VAD) have a survival advantage over extracorporeal membrane oxygenat

200 layed a significant infection dose-dependent survival advantage over fibrinogen-deficient mice follow

201 m/CDDP) combination has demonstrated a clear survival advantage over gemcitabine alone and has become

202 on on fully mature ASCs provides a selective survival advantage over less mature, newly minted ASCs,

203 ispanic patients with cirrhosis experience a survival advantage over many other racial groups despite

204 95% CI, 0.74-0.92) neighborhoods incurred a survival advantage over men, but there were no statistic

205 aneous coronary intervention did not offer a survival advantage over optimal medical therapy (HR, 0.9

206 for abdominal aortic aneurysm has an initial survival advantage over OR, but more frequent complicati

207 ptake, and produce metabolites that confer a survival advantage over pathogens.

208 egy for atrial fibrillation does not offer a survival advantage over rate control in heart failure pa

209 ; OR 0.86) and the most educated had a small survival advantage over the least educated (-3.9 deaths/

210 Newborns of the richest mothers had a small survival advantage over the poorest in unadjusted analys

211 y known as bilateral IMAs (BIMAs) provides a survival advantage over the use of LIMA alone.

212 R(-/-) mice with WT marrow had a significant survival advantage over their counterparts with IFN-alph

213 life-history theory: early offspring have a survival advantage over those produced later.

214 lomustine plus bevacizumab did not confer a survival advantage over treatment with lomustine alone i

215 bodied species, N. macrotis, and hybrids had survival advantages over the larger-bodied N. fuscipes i

216 Extra margin width did not add disease-free survival advantage (P > 0.05).

217 we show that primary human monocytes have a survival advantage, proliferate in vivo and develop into

218 The epithelial cell-autonomous survival advantage provided by IDO1 to colon epithelial

219 79) SETD8 inhibition conferred a significant survival advantage, providing evidence for SETD8 as a th

220 identified in the current study offer clear survival advantage, providing fast efficient transformat

221 wild-type N. gonorrhoeae strain FA1090 has a survival advantage relative to a PEA transferase A (lptA

222 ith primitive LSK cells having a significant survival advantage relative to more mature cells, consis

223 However, a substantial survival advantage remains for babies born into wealthie

224 The survival advantage seen in noninteracting combinations s

225 Surgery conferred no long-term survival advantage, so more efforts are needed to reduce

226 However, it is unclear if this survival advantage stems from the improved intravascular

227 y while providing a glutamine-dependent cell survival advantage, strongly suggests a metabolic surviv

228 men, but black race became associated with a survival advantage, suggesting that racial differences i

229 weight newborns from HbAC mothers may have a survival advantage that contributes to the natural selec

230 rysm was associated with a substantial early survival advantage that gradually decreased over time.

231 to avoid PA14 display a PA14 avoidance-based survival advantage that is also prg-1 dependent, suggest

232 translation may provide a context-dependent survival advantage that must be considered as a possible

233 in acute myeloid leukemia (AML) results in a survival advantage that promotes the malignant phenotype

234 ), the combination therapy did not provide a survival advantage; the median overall survival was 9.1

235 ead of the classical ATM-Chk2 DDR, Mtb gains survival advantage through ATM-Akt signaling cascade.

236 growth by providing GAB2-expressing cells a survival advantage through upregulation of BCL-2 family

237 ng expression of Tn/STn may offer tumor cell survival advantages through altering DR4 and/or DR5 acti

238 If there is a survival advantage to any strategy, it is likely to be s

239 we report that loss of p53 did not provide a survival advantage to B cells, as they underwent rapid a

240 d metabolic state transitions that confers a survival advantage to cancer cells against clinically us

241 llular NF-kappaB depot potentially confers a survival advantage to CD5(hi) T cells over CD5(lo) ones.

242 egulation of survivin and thereby provides a survival advantage to cells exposed to oxidative stress

243 ng a metabolic state that confers a profound survival advantage to cells in poorly vascularized tumou

244 nificantly, overexpression of ECD provided a survival advantage to cells upon ER stress induction.

245 R patients can be avoided, there is no early survival advantage to EVAR.

246 bachia also confers a weak, but significant, survival advantage to flies attacked by L. heterotoma.

247 se mutation in the Miocene likely provided a survival advantage to help maintain glucose levels under

248 tion, and ultimately conferred a significant survival advantage to infected mice.

249 ns, yet it was unknown if LLO could confer a survival advantage to L. monocytogenes in neutrophils.

250 We found a strong survival advantage to larger eggs and faster juvenile me

251 Inactivation of Jonah66Ci provides a survival advantage to larvae against axenic nematodes an

252 survival following TAC, it did not confer a survival advantage to mice following aortocaval shunt.

253 ion of nelfinavir and consequently conferred survival advantage to nelfinavir cytotoxicity.

254 c prescription of beta-blockers may confer a survival advantage to patients who subsequently develop

255 rowth of pancreatic neoplasia, and conferred survival advantage to PDA-bearing mice.

256 that this metabolic reprogramming provided a survival advantage to photoreceptors in an experimental

257 f the antiapoptotic protein Mcl-1 provides a survival advantage to some cancer cells, making inhibiti

258 Interestingly, bioluminescence conferred a survival advantage to the bacteria following ara-C treat

259 lter host immune responses, thus providing a survival advantage to the bacterium.

260 ntibiotics have long been assumed to yield a survival advantage to the producing bacteria in the high

261 of pregnant women with PfSEA-1 may afford a survival advantage to their offspring.

262 ssociated with transplantation may provide a survival advantage to transplant recipients with sepsis

263 , suggesting that PRL-3 provides a strategic survival advantage to tumour cells via its effects on mT

264 ose Small observational studies have shown a survival advantage to undergoing cancer-directed surgery

265 nse-counterdefense strategies seem to confer survival advantages to both the organisms, one of the po

266 m of multicellular organization that confers survival advantages to constituent cells.

267 Finally, narciclasine provides dramatic survival advantages to mice in two distinct mouse xenogr

268 hat leads to reduced ROS levels and provides survival advantages to the white cells.

269 c oncogene, given that it confers growth and survival advantages to these cells, whereas its inhibiti

270 ent LysM (cre) Mcl1 (fl/fl) mice that had no survival advantage under anti-PNAG treatment.

271 o sensory stimuli, indicative of a potential survival advantage under environmental challenges.

272 1-CDA axis of the adaptive UPR that provides survival advantage upon ER stress induction.

273 f Myc oncogene, whereas mutant cells empower survival advantage upon overgrowth and glucose deprivati

274 However, this ECLS survival advantage was found to occur primarily at high

275 Women's survival advantage was markedly diminished in hemodialys

276 The survival advantage was not observed when absolute dense

277 No survival advantage was observed after censoring patients

278 No significant survival advantage was observed in IPAH patients who sta

279 This survival advantage was persistent using multiple matchin

280 In our cecal slurry model, no survival advantage was seen among matrix metalloproteina

281 A modestly more pronounced survival advantage was seen for foreign-born Hispanics l

282 An overall survival advantage was seen with maintenance olaparib ve

283 scription (STAT) pathway provides cells with survival advantage, we wondered whether BCR stimulation

284 Increased expression of AAC-11 confers a survival advantage when cancer cells are challenged with

285 rix metalloproteinase-8 null intestine had a survival advantage when compared with mice receiving wil

286 8 null mice receiving wild-type marrow had a survival advantage when compared with wild-type mice rec

287 with high-risk phenotypes, which gave them a survival advantage when exposed to predators.

288 acids and glucose, TSC2(-/-) MEFs also had a survival advantage when extracellular amino acids and gl

289 der basal conditions, it provided a powerful survival advantage when proteasome function was impaired

290 is adaptation occurs too slowly to provide a survival advantage when there is a sudden change in envi

291 esistant genes and pathogens may only gain a survival advantage where antibiotic selection pressures

292 a's northward spread by 76 km, and that this survival advantage will persist under future climates.

293 gest reported follow-up show a breast cancer survival advantage with 10-year durations of tamoxifen u

294 D-1 antibody bound T cells and demonstrate a survival advantage with addition of a TIM-3 blocking ant

295 t trials of PCI vs. CABG demonstrated a late survival advantage with anatomy-based CABG.

296 The perioperative survival advantage with endovascular repair was sustaine

297 Conclusion We found a modest survival advantage with higher intake of protein, regard

298 In vivo, IL-4Ra-deficient neutrophils had a survival advantage within a hypoxic inflamed niche; in c

299 modulates the host immune response to gain a survival advantage within the host.

300 , we found that aggressive individuals had a survival advantage within their nest, but foundress grou